What is Hello Heart?
Hello Heart is a pioneering digital therapeutics company dedicated to addressing heart disease, the leading cause of mortality among U.S. adults. Leveraging a connected device and a sophisticated mobile application, the company employs AI, behavioral science, and personalized digital coaching to foster sustainable lifestyle changes. This approach empowers individuals to proactively manage their health, thereby mitigating risks associated with high blood pressure and heart disease. The platform also facilitates early detection of critical blood pressure readings, prompting timely medical consultation. Integrated seamlessly within employer benefits ecosystems, Hello Heart offers an accessible and user-friendly solution. Established in 2013, the company is recognized for its contributions as a member of the American Heart Association's Innovators Network and its participation in the CVS Health Point Solutions Management program.
How much funding has Hello Heart raised?
Hello Heart has raised a total of $136M across 4 funding rounds:
Series A
$9M
Series B
$12M
Series C
$45M
Series D
$70M
Series A (2018): $9M with participation from BlueRun Ventures, Resolute Ventures, and Maven Ventures
Series B (2019): $12M led by Blue Run Ventures and Khosla Ventures
Series C (2021): $45M supported by BlueRun Ventures, Resolute.Vc, Khosla Ventures, Maven Ventures, and IVP
Series D (2022): $70M featuring Stripes
Key Investors in Hello Heart
Blue Run Ventures
Blue Run Ventures is a venture capital fund established in 1998, with a global presence including offices in Menlo Park, Beijing, Helsinki, Mumbai, Seoul, and Shanghai. They focus on investing in innovative companies.
Khosla Ventures
Khosla Ventures, founded in 2004, provides venture assistance and strategic advice to entrepreneurs developing breakthrough technologies. They manage over fourteen billion dollars and invest across diverse sectors including AI, fintech, health, and sustainable energy.
Stripes
Stripes is an investment firm that has participated in Hello Heart's funding rounds. Further details on their investment focus are not readily available from the provided data.
What's next for Hello Heart?
The substantial enterprise-level funding Hello Heart has garnered, particularly the recent strategic investment, positions the company for accelerated growth and market expansion. This capital infusion is expected to fuel further development of its AI-driven platform, enhance its coaching capabilities, and broaden its reach within employer health benefit programs. The company's focus on chronic disease management, specifically heart health, aligns with the growing demand for preventative and digital-first healthcare solutions. Future strategic initiatives will likely involve deepening partnerships with healthcare providers and insurers, as well as exploring new therapeutic areas beyond cardiovascular health, solidifying its role as a key player in the digital therapeutics landscape.
See full Hello Heart company page
